PKM and central nervous system cancer: These discoveries showed that overexpression of PKM2 can reverse the influence of trametinib on migration, invasion, glycolysis level, and apoptosis rate in glioma cells, which also indicates that PKM2 plays an essential role in the mechanism by which trametinib kills glioma.